EUVIMEDEUVIMED entdecken
Crossref

Commentary on Negative Sweat Chloride Testing in the Setting of a Positive Newborn Screen and CFTR Compound Heterozygosity

Mark A Cervinski iD

Clinical Chemistry · 2024

DOI: 10.1093/clinchem/hvae117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Chemistry, 2024. Verfasst von Mark A Cervinski. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, United States. Hauptthemen laut MEDLINE: Cystic Fibrosis Transmembrane Conductance Regulator, Sweat, Neonatal Screening, Chlorides. Die Arbeit nennt 2 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic Fibrosis Transmembrane Conductance RegulatorSweatNeonatal ScreeningChloridesCystic FibrosisHumansInfant, NewbornHeterozygote

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorChloridesCFTR protein, human

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, United States.
  • The Geisel School of Medicine at Dartmouth, Hanover, NH, United States.

ORCID-Profile: Mark A Cervinski

Zitieren

APA

Cervinski, M. A. (2024). Commentary on Negative Sweat Chloride Testing in the Setting of a Positive Newborn Screen and CFTR Compound Heterozygosity. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvae117

Vancouver

Cervinski MA. Commentary on Negative Sweat Chloride Testing in the Setting of a Positive Newborn Screen and CFTR Compound Heterozygosity. Clinical Chemistry. 2024. doi:10.1093/clinchem/hvae117

BibTeX
@article{Cervinski2024,
  author = {Cervinski, Mark A},
  title = {Commentary on Negative Sweat Chloride Testing in the Setting of a Positive Newborn Screen and CFTR Compound Heterozygosity},
  journal = {Clinical Chemistry},
  year = {2024},
  doi = {10.1093/clinchem/hvae117}
}
Kostenlos starten →